Learn more about how Capital Investments can support your strategic and financial goals through customized solutions and services. Get in touch today
CANCEL
BACK
HIKMA PHARMACEUTICALS
OVERVIEW
  • When Hikma Pharmaceuticals sought to complete its initial public offering (IPO) in 2005, it reached out to Capital Investments to serve as its co-lead manager in handling the pharmaceutical company’s debut on the London Stock Exchange.
OUTCOME
  • Hikma’s IPO represented a major milestone, as the first Jordanian company to be listed on the London Stock Exchange. The successful completion of Hikma’s initial public offering helped propel the company onto the global stage as a major player in the international pharmaceutical industry.